A detailed history of Victory Capital Management Inc transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Victory Capital Management Inc holds 24,627 shares of SGMO stock, worth $28,321. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,627
Previous 23,779 3.57%
Holding current value
$28,321
Previous $20,000 25.0%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 06, 2025

BUY
$0.78 - $2.87 $661 - $2,433
848 Added 3.57%
24,627 $25,000
Q3 2024

Nov 05, 2024

SELL
$0.32 - $1.1 $102 - $353
-321 Reduced 1.33%
23,779 $20,000
Q2 2024

Aug 05, 2024

BUY
$0.36 - $0.65 $8,676 - $15,665
24,100 New
24,100 $8,000
Q3 2023

Nov 06, 2023

BUY
$0.58 - $1.47 $433 - $1,098
747 Added 4.67%
16,738 $10,000
Q2 2023

Jul 27, 2023

BUY
$1.11 - $1.74 $1,405 - $2,202
1,266 Added 8.6%
15,991 $20,000
Q1 2023

May 02, 2023

SELL
$1.66 - $3.67 $332 - $734
-200 Reduced 1.34%
14,725 $25,000
Q4 2022

Feb 09, 2023

SELL
$2.77 - $5.07 $16 - $30
-6 Reduced 0.04%
14,925 $46,000
Q3 2022

Nov 02, 2022

SELL
$4.27 - $6.39 $4,000 - $5,987
-937 Reduced 5.9%
14,931 $73,000
Q2 2022

Aug 01, 2022

SELL
$3.28 - $6.21 $95 - $180
-29 Reduced 0.18%
15,868 $66,000
Q1 2022

May 04, 2022

SELL
$5.23 - $7.82 $2,201 - $3,292
-421 Reduced 2.58%
15,897 $66,000
Q4 2021

Feb 07, 2022

SELL
$7.29 - $10.97 $5,008 - $7,536
-687 Reduced 4.04%
16,318 $122,000
Q3 2021

Nov 02, 2021

SELL
$9.01 - $12.01 $4,072 - $5,428
-452 Reduced 2.59%
17,005 $153,000
Q2 2021

Aug 03, 2021

SELL
$10.17 - $12.64 $4,718 - $5,864
-464 Reduced 2.59%
17,457 $209,000
Q1 2021

May 04, 2021

SELL
$10.88 - $17.05 $3,525 - $5,524
-324 Reduced 1.78%
17,921 $225,000
Q4 2020

Feb 01, 2021

BUY
$9.23 - $18.18 $11,177 - $22,015
1,211 Added 7.11%
18,245 $285,000
Q3 2020

Nov 09, 2020

SELL
$9.38 - $12.48 $11,302 - $15,038
-1,205 Reduced 6.61%
17,034 $161,000
Q2 2020

Aug 07, 2020

SELL
$6.21 - $11.83 $2,806 - $5,347
-452 Reduced 2.42%
18,239 $163,000
Q1 2020

May 04, 2020

SELL
$5.05 - $8.85 $19,760 - $34,630
-3,913 Reduced 17.31%
18,691 $119,000
Q4 2019

Feb 06, 2020

BUY
$8.03 - $11.7 $28,096 - $40,938
3,499 Added 18.31%
22,604 $189,000
Q4 2019

Feb 04, 2020

SELL
$8.03 - $11.7 $3,380 - $4,925
-421 Reduced 2.16%
19,105 $140,000
Q3 2019

Nov 12, 2019

BUY
$9.05 - $12.22 $176,710 - $238,607
19,526 New
19,526 $177,000

Others Institutions Holding SGMO

About SANGAMO THERAPEUTICS, INC


  • Ticker SGMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 156,552,992
  • Market Cap $180M
  • Description
  • Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...
More about SGMO
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.